Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.94 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | CASP1 | P29466 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.52 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinoline SCHEMBL29558745 | 1.00 | ALDH1A1 (0.94) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL5714730 | 1.00 | ALDH1A1 (0.94) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL2790221 | 1.00 | ALDH1A1 (0.94) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL28067914 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL28099332 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL28138908 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL27657334 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL28089949 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL28162459 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 | |
| Quinoline SCHEMBL28131670 | 0.97 | ALDH1A1 (0.90) | ALDH1A1NPC1POLBRAB9ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 627 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529141-A | Preparation method of quinoline amino binuclear metal titanium zirconium hafnium catalyst and application of catalyst in olefin polymerization | 青岛科技大学 | 2025-02-28 | — | — | CN | claimed |
| CN-119390880-A | Preparation method of ultrahigh molecular weight propylene-based elastomer | 青岛科技大学 | 2025-02-07 | — | — | CN | claimed |
| US-20230390406-A1 | Star Polymer Drug Conjugates | BARINTHUS BIOTHERAPEUTICS NORTH AMERICA, INC. | 2023-12-07 | — | — | US | claimed |
| EP-4228701-A1 | STAR POLYMER DRUG CONJUGATES | Vaccitech North America, Inc. (US) | 2023-08-23 | — | — | EP | claimed |
| CN-109771657-B | High-molecular antitumor drug bonded with vascular blocking agent and immunomodulator and preparation method thereof | 湘潭大学 | 2022-06-24 | — | — | CN | claimed |
| WO-2022086853-A1 | STAR POLYMER DRUG CONJUGATES | AVIDEA TECHNOLOGIES, INC. (US) | 2022-04-28 | — | — | WO | claimed |
| CN-111909163-B | Quinolamine compound with IDO1 inhibition function and preparation method thereof | 南开大学 | 2022-02-01 | — | — | CN | claimed |
| CN-111777608-B | Novel plant modified quinoline quaternary ammonium salt compound, preparation method and application | 湖北精瑜材料有限公司 | 2021-08-03 | — | — | CN | claimed |
| CN-112795375-A | Controllable release solid acid material and preparation method and application thereof | 南京科匠新材料技术开发有限公司 | 2021-05-14 | — | — | CN | claimed |
| CN-108707144-B | Chiral quinoline amine compound and preparation method and application thereof | 浙江大学 | 2020-11-24 | — | — | CN | claimed |
| US-20050226878-A1 | Therapeutic combinations and methods including IRM compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2005-10-13 | — | — | US | claimed |
| CN-1681470-A | Agent for dyeing keratinous fibres | HENKEL KGAA (DE) | 2005-10-12 | — | — | CN | claimed |
| WO-2004080292-A2 | METHOD OF TATTOO REMOVAL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-09-23 | — | — | WO | claimed |
| US-20040181211-A1 | Method of tattoo removal | 3M INNOVATIVE PROPERTIES COMPANY | 2004-09-16 | — | — | US | claimed |
| WO-2004071459-A2 | METHODS AND COMPOSITIONS RELATED TO IRM COMPOUNDS AND TOLL-LIKE RECEPTOR 8 | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-08-26 | — | — | WO | claimed |
| US-20040162309-A1 | Methods and compositions related to IRM compounds and toll-like receptor 8 | 3M INNOVATIVE PROPERTIES COMPANY | 2004-08-19 | — | — | US | claimed |
| EP-1100802-B1 | OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLINE-4-AMINES AND ANALOGS THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2003-09-24 | — | — | EP | claimed |
| CN-1164185-A | Lyophilized preparation providing reversibly thermogelling water-base medicinal composition | WAKAMOTO PHARMA CO LTD (JP) | 1997-11-05 | — | — | CN | claimed |
| US-5084210-A | A mixture of a cyclic quaternary amine, a surfactant, an acety lenic alcohol and a solvent effective to inhibit oxidation | CHEMLINK INCORPORATED (US) | 1992-01-28 | — | — | US | claimed |
| US-4691062-A | Process for the production of 4-chloro-butanals | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1987-09-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230390406-A1 | Star Polymer Drug Conjugates | CCND3, CCND2, DRD3 | ALDH1A1 1987/4885NPC1 1748/4885POLB 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.